These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 1466869)

  • 21. Indication, efficiency and complications of intrathecal pump supported baclofen treatment in spinal spasticity.
    Saltuari L; Kronenberg M; Marosi MJ; Kofler M; Russegger L; Rifici C; Bramanti P; Gerstenbrand F
    Acta Neurol (Napoli); 1992 Jun; 14(3):187-94. PubMed ID: 1442217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complications of intrathecal baclofen delivery.
    Teddy P; Jamous A; Gardner B; Wang D; Silver J
    Br J Neurosurg; 1992; 6(2):115-8. PubMed ID: 1590964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin.
    Armstrong RW; Steinbok P; Cochrane DD; Kube SD; Fife SE; Farrell K
    J Neurosurg; 1997 Sep; 87(3):409-14. PubMed ID: 9285607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuously infused intrathecal baclofen for spastic/dystonic hemiplegia: a preliminary report.
    Meythaler JM; Guin-Renfroe S; Hadley MN
    Am J Phys Med Rehabil; 1999; 78(3):247-54. PubMed ID: 10340423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term intrathecal baclofen infusion for treatment of spasticity.
    Penn RD; Kroin JS
    J Neurosurg; 1987 Feb; 66(2):181-5. PubMed ID: 3806200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrathecal baclofen in hereditary spastic paraparesis.
    Meythaler JM; Steers WD; Tuel SM; Cross LL; Sesco DC; Haworth CS
    Arch Phys Med Rehabil; 1992 Sep; 73(9):794-7. PubMed ID: 1514885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A benefit-risk assessment of baclofen in severe spinal spasticity.
    Dario A; Tomei G
    Drug Saf; 2004; 27(11):799-818. PubMed ID: 15350152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal baclofen: does tolerance occur?
    Akman MN; Loubser PG; Donovan WH; O'Neill ME; Rossi CD
    Paraplegia; 1993 Aug; 31(8):516-20. PubMed ID: 8414636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin.
    Zahavi A; Geertzen JH; Middel B; Staal M; Rietman JS
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1553-7. PubMed ID: 15489386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults.
    Borrini L; Bensmail D; Thiebaut JB; Hugeron C; Rech C; Jourdan C
    Arch Phys Med Rehabil; 2014 Jun; 95(6):1032-8. PubMed ID: 24407102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological complications of the chronic baclofen infusion in the severe spinal spasticity. Personal experience and review of the literature.
    Dario A; Scamoni C; Picano M; Casagrande F; Tomei G
    J Neurosurg Sci; 2004 Dec; 48(4):177-81. PubMed ID: 15876986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limitations of intrathecal baclofen for spastic hemiparesis following stroke.
    Kofler M; Quirbach E; Schauer R; Singer M; Saltuari L
    Neurorehabil Neural Repair; 2009 Jan; 23(1):26-31. PubMed ID: 18796543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implanted pump systems for treatment of spasticity.
    Zierski J; Müller H; Dralle D; Wurdinger T
    Acta Neurochir Suppl (Wien); 1988; 43():94-9. PubMed ID: 3213666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrathecal baclofen therapy for spasticity of cerebral origin--does the position of the intrathecal catheter matter?
    Sivakumar G; Yap Y; Tsegaye M; Vloeberghs M
    Childs Nerv Syst; 2010 Aug; 26(8):1097-102. PubMed ID: 20306056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study.
    Van Schaeybroeck P; Nuttin B; Lagae L; Schrijvers E; Borghgraef C; Feys P
    Neurosurgery; 2000 Mar; 46(3):603-9; discussion 609-12. PubMed ID: 10719857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of severe spasticity with intrathecal baclofen delivered by a manually operated pump.
    Patterson V; Watt M; Byrnes D; Crowe D; Lee A
    J Neurol Neurosurg Psychiatry; 1994 May; 57(5):582-5. PubMed ID: 8201328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrathecal baclofen infusion: an innovative approach for controlling spinal spasticity.
    Savoy SM; Gianino JM
    Rehabil Nurs; 1993; 18(2):105-13. PubMed ID: 8451504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subarachnoid-to-Subarachnoid Shunt for Correction of Nonfunctioning Baclofen Pump in a Severe Case of Chronic Debilitating Post-Spinal Cord Injury Spasticity.
    Bakare AA; Weyhenmeyer J; Lee A
    World Neurosurg; 2018 Feb; 110():26-29. PubMed ID: 29101071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examining the effectiveness of intrathecal baclofen on spasticity in individuals with chronic spinal cord injury: a systematic review.
    McIntyre A; Mays R; Mehta S; Janzen S; Townson A; Hsieh J; Wolfe D; Teasell R
    J Spinal Cord Med; 2014 Jan; 37(1):11-8. PubMed ID: 24089997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience.
    Meythaler JM; Guin-Renfroe S; Grabb P; Hadley MN
    Arch Phys Med Rehabil; 1999 Jan; 80(1):13-9. PubMed ID: 9915366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.